Zantac Tied to Infant Testicular Cancer
In September 2019, the FDA announced concerns that the prescription and OTC medication, Zantac could cause testicular cancer in children. This announcement came after an online pharmacy tested Zantac tablets and found a cancer-causing chemical, NDMA, at levels up to 3,000 times greater than the FDA’s legally allowable limit. Zantac & NDMA Zantac (Ranitidine) decreases
Read More